CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Honz Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Honz Pharmaceutical Co Ltd
No. 6
Yaogu Third Road, Yaogu Industrial Park
Phone: +86 89866812876p:+86 89866812876 HAIKOU, HAN  570311  China Ticker: 300086300086
Business Summary
HONZ PHARMACEUTICAL CO., LTD., formerly HAINAN HONZ PHARMACEUTICAL CO., LTD., is principally engaged in the research, development, production and distribution of drugs for children. The Company provides western medicines and Chinese patent drugs, including antipyretic and analgesic drugs, cold drugs, antibiotics drugs, respiratory system drugs, digestant and arresting convulsion drugs, as well as nutrition drugs, among others. The Company's products include nimesulide granules, cefminox sodium for injection, Zhike Juhong granules, Ganmao Qingre granules, artificial cow-bezoar and chlorphenamine maleate granules, cefaclor granules, carbocisteine granules, Jianerle granules, pediatric four vitaminsand calcium gluconate granules, as well as ribavirin pellets and Norfloxacin capsules for adults.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202312/31/2022Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
3842 Orthopedic, prosthetic, and surgical appliances and supplies
2844 Perfumes, cosmetics, and other toilet preparations
2841 Soap and other detergents, except specialty cleaners
2621 Paper mills
8062 General medical and surgical hospitals

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board JiangyouHong 58 12/19/2019
President JiangtaoHong 52 12/19/2019 12/19/2019
Vice Chairman of the Board, Vice President LipingHong 54 12/19/2019
7 additional Officers and Directors records available in full report.

Business Names
Business Name
300086
HAINAN HONZ PHARMACEUTICAL CO.,LTD.

General Information
Number of Employees: 843 (As of 12/31/2022)
Outstanding Shares: 450,000,000 (As of 9/30/2023)
Shareholders: 47,391
Stock Exchange: SHE
Fax Number: +86 89866812876


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 25, 2024